Ranchi News Desk

Gene Therapy Market Is Anticipated to Grasp $4,402 Million By 2023, With Recording a CAGR of 33.3% | Allied Market Research

 Breaking News
  • No posts were found

Gene Therapy Market Is Anticipated to Grasp $4,402 Million By 2023, With Recording a CAGR of 33.3% | Allied Market Research

September 02
12:45 2019
Gene Therapy Market Is Anticipated to Grasp $4,402 Million By 2023, With Recording a CAGR of 33.3% | Allied Market Research

Gene Therapy Market
Increase in awareness in regards with the benefits of using gene therapy as compared to conventional therapy for the treatment of various diseases and government support to promote gene therapy related research are the major driving factors that are projected to boost the market growth

Gene Therapy Market is expected to reach $4,402 million by 2023 from $784 million in 2017, registering a CAGR of 33.3%.

The growth of the global gene therapy market is driven by an increase in prevalence of cancer, high R&D investment in gene therapy, and growing awareness concerning gene therapy in particular. Additionally, the untapped potential for emerging markets would create lucrative opportunities for new market players. However, high cost associated with gene therapy and unwanted immune responses as a result of treatment hamper market growth.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2841

The report offers an analysis of the market dynamics which include the growth drivers, restraints and opportunities.  Increase in funding for R&D activities pertaining to gene therapy and increase in awareness regarding gene therapy drive the market. Nonetheless, high cost associated with the treatment and unwanted immune responses restrict the growth of the industry. Conversely, increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in prevalence of cancer offer new opportunities for the growth of the market.

The report offers a broad segmentation of the global gene therapy market. It segments the market into vector type, gene type, applications, and geography. Based on vector type, it is classified into viral vector and non-viral vector. The viral vector segment captured more than half of the market share in 2017 and is likely to remain dominant during the forecast period. The gene type segment is bifurcated into antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others. The tumor suppressor segment is expected to grow at the fastest CAGR of 35.5% during the study period. The applications segment is divided into oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. The oncological disorders segment is likely to dominate in terms of revenue through 2023. The market study covers various geographical locations such as North America, Europe, Asia-Pacific, and LAMEA.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2841

KEY FINDINGS OF GENE THERAPY MARKET STUDY  

  • Non-viral vectors is projected to grow at the highest rate during the analysis period.
  • Oncological disorders segment generated the highest revenue, and is expected to continue its dominance in future.
  • North America dominated global gene therapy market in 2016, and is projected to continue its dominance in future.
  • China is expected to grow highest in the Asia-Pacific region during the forecast period.
  • Antigen was the largest contributor among the gene type segments.

The report also includes an analysis of the leading players operating in the gene therapy market. They include Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.

Similar Reports:

High-intensity Focused Ultrasound (HIFU) Therapy Market – Global Opportunity Analysis and Industry Forecast, 2018-2025

Infant Phototherapy Devices Market – Global Opportunity Analysis and Industry Forecast, 2017-2023

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States
Website: www.alliedmarketresearch.com/gene-therapy-market